https://ppubs.uspto.gov/pubwebapp/
Portage Biotech Reports Fiscal Year-Ended March 31, 2023 Financial Results And Business Update; FY23 EPS $(6.49) Vs $(1.29) YoY
Company poised to accelerate accrual in all clinical programs as it activates numerous sites across multiple U.S. cities and abroad and takes over sponsorship from the investigator-led program
Updated interim
